Hypoglycaemia and the Older Person

  • Simon C. M. Croxson


Hypoglycaemia is classically defined by Whipple’s Triad; it looks like a hypo, plasma glucose level is low, and the patient gets better with treatment [1]. In clinical diabetes, 4.0 mmol/L is taken as the threshold for hypoglycaemia which is often classified as mild if the patient can treat and correct it themselves, or severe if external assistance is required; hypos may however be classified as needing no treatment, treated by patient, treated by external assistance orally, or treated by external assistance parenterally. The glucose level used to define hypoglycaemia is lower for other purposes such as endocrine testing.


Glycaemic Control Continuous Glucose Monitoring Hypoglycaemic Episode Electrocardiographic Abnormality Tight Glycaemic Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    American Diabetes Association Workgroup On Hypoglycemia Defining and reporting hypoglycemia in diabetes. Diabetes Care, 2005;28:1245–1249.CrossRefGoogle Scholar
  2. 2.
    Jaap AJ, Jones GC, McCrimmon RJ, Deary IJ, Frier BM. Perceived symptoms of hypoglycaemia in elderly Type 2 diabetic patients treated with insulin. Diabet. Med. 1998;15:398–401.PubMedCrossRefGoogle Scholar
  3. 3.
    Matyka K, Evans M, Lomas J, Cranston I, Macdonald I, Amiel SA. Altered hierarchy of protective responses against severe hypoglycaemia in normal ageing in healthy men. Diabetes Care 1997;20:135–141.PubMedCrossRefGoogle Scholar
  4. 4.
    Brierley EJ, Broughton DL, James OF, Alberti KG. Reduced awareness of hypoglycaemia in the elderly despite an intact counter-regulatory response. QJM. 1995;88:439–45.PubMedGoogle Scholar
  5. 5.
    Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with Type 2 diabetes. Diabetes Care 2009;32:1513–1517.PubMedCrossRefGoogle Scholar
  6. 6.
    Munshi MN, Segal AR, Suhl E, Staum E; Desrochers L, Sternthal, Giusti J, McCartney R, Lee Y, Bonsignore P, Weinger K. Frequent Hypoglycemia Among Elderly Patients With Poor Glycemic Control. Arch Intern Med. 2011;171:362–364.Google Scholar
  7. 7.
    Thomson FJ, Masson EA, Leeming JT, Boulton AJ Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Age Ageing. 1991;20:404–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Heller S, Chapman J, McCloud J, Ward J. Unreliability of reports of hypoglycaemia by diabetic patients. BMJ. 1995;310:440.PubMedGoogle Scholar
  9. 9.
    McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med. 2001;18:690–705.PubMedCrossRefGoogle Scholar
  10. 10.
    Croxson SCM. Hypoglycaemia, cognition and the older person with diabetes. Pract Diab Int 2010;27:219–220.CrossRefGoogle Scholar
  11. 11.
    Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycaemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997;157:1681–1686.PubMedCrossRefGoogle Scholar
  12. 12.
    Gough SC. A review of human and analogue insulin trials. Diabetes Res Clin Pract. 2007;77:1–15.PubMedCrossRefGoogle Scholar
  13. 13.
    Aslpund K, Wihilm B-E, Lithner F. Glibenclamide associated hypoglycaemia; a report on 57 cases. Diabetologia 1983;24:412–417.Google Scholar
  14. 14.
    Stahl M, Berger W. Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long-­acting versus short-acting sulphonylureas. Diabet Med 1999;16: 586–90.PubMedCrossRefGoogle Scholar
  15. 15.
    Shorr RI, Ray WA, Daugherty JR, Griffin MR. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc. 1996;44:751–5.PubMedGoogle Scholar
  16. 16.
    Harrower AD, Wong C. Comparison of secondary failure rate between three second generation sulphonylureas. Diabetes Res. 1990;13(1):19–21.PubMedGoogle Scholar
  17. 17.
    Croxson S, Chapter 19: Diabetes mellitus & common endocrine conditions in the elderly. In Crome P, Ford G, (Eds) Drugs & the older population. London: Imperial College Press, 2000, 453–531.CrossRefGoogle Scholar
  18. 18.
    Black C, Donnelly P, McIntyre L, Royle PL, Shepherd JP, Thomas S. Meglitinide analogues for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD004654. DOI:  10.1002/14651858.CD004654.pu3.
  19. 19.
    Morris AD, Boyle DI, McMahon AD et al ACE inhibitor use is ­associated with hospitalization for hypoglycemia in patients with diabetes. Diabetes Care 1997;20:1363–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Herings RM, de Boer A, Stricker BH, Leufkens HG, Porsius A. Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995;345:1195–8.PubMedCrossRefGoogle Scholar
  21. 21.
    A H Barnett, D Leslie, and P J Watkins. Can insulin-treated ­diabetics be given beta-adrenergic blocking drugs? B M J. 1980;280: 976–978.CrossRefGoogle Scholar
  22. 22.
    Benbow SJ, Hoyte R, Gill GV. Institutional dietary provision for diabetic patients. QJM. 2001;94:27–30.PubMedCrossRefGoogle Scholar
  23. 23.
    Mooradian AD, Osterweil D, Petrasek D, Morley JE. Diabetes mellitus in elderly nursing home patients. A survey of clinical characteristics and management. J Am Geriatr Soc. 1988;36:391–6.PubMedGoogle Scholar
  24. 24.
    UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33): Lancet 1998;352:837–853.CrossRefGoogle Scholar
  25. 25.
    The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med1993;329:977–986.CrossRefGoogle Scholar
  26. 26.
    Paisey RB, Read R, Palmer R, and Hartog M. Persistent fetal haemoglobin and falsely high glycosylated haemoglobin levels. BMJ (Clin Res Ed). 1984;289:279–280.CrossRefGoogle Scholar
  27. 27.
    Simon D, Senan C, Garnier P, Saint-Paul M, Papoz L. Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia. 1989;32:864–9.Google Scholar
  28. 28.
    Kilpatrick ES, Dominiczak MH, Small M. The effects of ageing on glycation and the interpretation of glycaemic control in Type 2 diabetes.QJM, 1996;89:307–12.PubMedGoogle Scholar
  29. 29.
    Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, Sullivan L, D’Agostino RB, Nathan DM. Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001–2004. Diabetes Care. 2008;31:1991–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD, Phillips LS. Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152: 770–7.PubMedGoogle Scholar
  31. 31.
    Kirk JK, D’Agostino RB Jr, Bell RA, Passmore LV, Bonds DE, Karter AJ, Narayan KM. Disparities in HbA1c levels between African-American and non-Hispanic white adults with diabetes: a meta-analysis. Diabetes Care. 2006;29:2130–6.PubMedCrossRefGoogle Scholar
  32. 32.
    Brooks AP, Metcalfe J, Day JL, Edwards MS. Iron deficiency and glycosylated haemoglobin A. Lancet. 1980;2:141.PubMedCrossRefGoogle Scholar
  33. 33.
    Davis RE, McCann VJ, Nicol DJ. Influence of iron-deficiency anaemia on the glycosylated haemoglobin level in a patient with diabetes mellitus. Med J Aust. 1983;1:40–1.PubMedGoogle Scholar
  34. 34.
    Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–9PubMedCrossRefGoogle Scholar
  35. 35.
    Croxson SCM. Chapter 3; Screening for diabetes. In Sinclair AJ, (Ed). Diabetes in old age (3nd edition). Chichester; John Wiley & Sons; 2009; pp 21–40.Google Scholar
  36. 36.
    Gold AE, Deary IJ, Jones RW, O’Hare JP, Reckless J, Frier BM. Severe deterioration in cognitive function and personality in five patients with longstanding diabetes: a complication of diabetes or a consequence of treatment. Diabet Med 1994;11:499–505.PubMedCrossRefGoogle Scholar
  37. 37.
    Croxson S, McConvey R, Molodynski L. Severe hypoglycaemia & cognitive impairment. Pract Diab Int 2001;18:315–316.CrossRefGoogle Scholar
  38. 38.
    Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP Jr, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–1572.PubMedCrossRefGoogle Scholar
  39. 39.
    Graveling AJ, Frier BM. Dementia and hypoglycemic episodes in patients with type 2 diabetes mellitus. JAMA. 2009 Aug 26;302:843.PubMedCrossRefGoogle Scholar
  40. 40.
    Whitmer RA, Karter AJ, Selby JV. Dementia and hypoglycemic episodes in patients with Type 2 diabetes mellitus—Reply. JAMA. 2009;302:843–844.CrossRefGoogle Scholar
  41. 41.
    The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose-lowering in type 2 diabetes. New Engl J Med 2008;358:2545–59.CrossRefGoogle Scholar
  42. 42.
    The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560–72.CrossRefGoogle Scholar
  43. 43.
    Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, Horowitz KR, Savage PJ, Seaquist ER, Simmons DL, Sivitz WI, Speril-Hillen JM, Sweeney ME. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909. doi:  10.1136/bmj.b4909.PubMedCrossRefGoogle Scholar
  44. 44.
    Desouza C, Salazar H, Cheong B, Murgo J, Fonseca V. Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring. Diabetes Care. 2003;26:1485–9.PubMedCrossRefGoogle Scholar
  45. 45.
    Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, Woodward M, Ninomiya T, Neal B, MacMahon S, Grobbee DE, Kengne AP, Marre M, Heller S, for the ADVANCE Collaborative Group. Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010;363:1410–1418PubMedCrossRefGoogle Scholar
  46. 46.
    Tzoulaki I, Molokhia M, Curcin V, Little MP, Millett CJ, Ng A, Hughes RI, Khunti K, Wilkins MR, Majeed A, Elliott P. Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. BMJ. 2009;339:b4731. doi:  10.1136/bmj.b4731.PubMedCrossRefGoogle Scholar
  47. 47.
    Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diabetes Metab Res Rev. 2008;24:353–63.PubMedCrossRefGoogle Scholar
  48. 48.
    Johnston V, Howe J, Davies M. Hospital admission secondary to hypoglycaemia in type 2 diabetes. J Diabetes Nursing 2002;6:51–55Google Scholar
  49. 49.
    Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pende. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009; 32:1153–7.Google Scholar
  50. 50.
    Mayne D, Stout NR, Aspray TJ. Diabetes, falls and fractures. Age Ageing. 2010;39:522–5.PubMedCrossRefGoogle Scholar
  51. 51.
    Nelson JM, Dufraux K, Cook PF. The relationship between glycemic control and falls in older adults. J Am Geriatr Soc. 2007; 55:2041–4.PubMedCrossRefGoogle Scholar
  52. 52.
    Schwartz AV, Vittinghoff E, Sellmeyer DE, Feingold KR, de Rekeneire N, Strotmeyer ES, Shorr RI, Vinik AI, Odden MC, Park SW, Faulkner KA, Harris TB; Health, Aging, and Body Composition Study. Diabetes-related complications, glycemic control, and falls in older adults. Diabetes Care. 2008;31:391–6.PubMedCrossRefGoogle Scholar
  53. 53.
    Berlie HD, Garwood CL. Diabetes medications related to an increased risk of falls and fall-related morbidity in the elderly. Ann Pharmacother. 2010;44:712–7.PubMedCrossRefGoogle Scholar
  54. 54.
    Schwartz AV, Sellmeyer DE, Ensrud KE, Cauley JA, Tabor HK, Schreiner PJ, Jamal SA, Black DM, Cummings SR; Study of Osteoporotic Features Research Group. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab. 2001;86:32–38.PubMedCrossRefGoogle Scholar
  55. 55.
    Monami M, Cresci B, Colombini A, Pala L, Balzi D, Gori F, Chiasserini V, Marchionni N, Rotella CM, Mannucci E. Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care. 2008;31:199–203.PubMedCrossRefGoogle Scholar
  56. 56.
    Allen KV, Frier BM. Nocturnal hypoglycemia: clinical manifestations and therapeutic strategies toward prevention. Endocr Pract. 2003;9:530–43.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2011

Authors and Affiliations

  • Simon C. M. Croxson
    • 1
  1. 1.Department of Medicine for the Elderly, Ward 17University Hospitals Bristol NHS Foundation Trust, Bristol Royal InfirmaryBristolUK

Personalised recommendations